Noemí Puig
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 73
- Multiple Myeloma Research and Treatments 62
- Genetics 29
- Chronic Lymphocytic Leukemia Research 19
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Ramón García‐SánzBruno PaivaAlberto ÓrfãoMaría‐Victoria MateosJacques J. M. van DongenJesús F. San MiguelJuan Flores‐MonteroMarcos González
- Journals
- Blood (22 papers)Cancers (9 papers)Annals of Hematology (5 papers)Haematologica (4 papers)Blood Cancer Journal (4 papers)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Noemí Puig
104 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Hematology 836
- Genetics 479
- Pathology and Forensic Medicine 393
- Oncology 532
- Immunology 399
Countries citing papers authored by Noemí Puig
This map shows the geographic impact of Noemí Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noemí Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noemí Puig more than expected).
Fields of papers citing papers by Noemí Puig
This network shows the impact of papers produced by Noemí Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noemí Puig. The network helps show where Noemí Puig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noemí Puig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 30 | |
| 5 | 2023 | 4 | |
| 6 | 2021 | 33 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 92 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 36 | |
| 11 | 2019 | 10 | |
| 12 | 2019 | 8 | |
| 13 | 2018 | 17 | |
| 14 | 2017 | 28 | |
| 15 | 2017 | 27 | |
| 16 | 2012 | 6 | |
| 17 | 2012 | 12 | |
| 18 | 2011 | 25 | |
| 19 | 2011 | 10 | |
| 20 | 2009 | 35 |
About Noemí Puig
Noemí Puig is a scholar working on Hematology, Genetics, Oncology, Immunology and Pathology and Forensic Medicine, having authored 111 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (62 papers), Peptidase Inhibition and Analysis (20 papers), Chronic Lymphocytic Leukemia Research (19 papers), Protein Degradation and Inhibitors (18 papers), Lymphoma Diagnosis and Treatment (16 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (836 citations), Genetics (479 citations), Pathology and Forensic Medicine (393 citations), Oncology (532 citations) and Immunology (399 citations). Noemí Puig has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Ramón García‐Sánz, Bruno Paiva, Alberto Órfão, María‐Victoria Mateos, Jacques J. M. van Dongen, Jesús F. San Miguel, Juan Flores‐Montero, Marcos González, Consuelo del Cañizo and Luis Ignacio Sánchez‐Abarca. Their work appears in journals such as Blood, Cancers, Annals of Hematology, Haematologica and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.